Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. (Q37453764)
Jump to navigation
Jump to search
scientific article published on July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. |
scientific article published on July 2007 |
Statements
Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7 (English)
Aglaia foveolata
1 reference
Soyoung Kim
Bao-Ning Su
Heebyung Chai
Qiuwen Mi
A Douglas Kinghorn
Robert Wild
Steven M Swanson
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference